Hormonal Effects on Tc-99m Sestamibi Uptake in the Breast
This study has been completed.
Information provided by (Responsible Party):
Deborah Rhodes, Mayo Clinic
First received: July 20, 2009
Last updated: January 23, 2012
Last verified: January 2012
This study is to examine the effects of menstrual cycle, hormone therapy, and the use of tamoxifen on Tc-99m sestamibi uptake.
|Study Design:||Observational Model: Case-Only
Time Perspective: Cross-Sectional
|Official Title:||Molecular Breast Imaging: Effect of Menstrual Cycle, Hormone Therapy, and Tamoxifen on Tc-99m Sestamibi Uptake in the Breast.|
Resource links provided by NLM:
U.S. FDA Resources
Further study details as provided by Mayo Clinic:
|Study Start Date:||January 2008|
|Study Completion Date:||January 2012|
|Primary Completion Date:||December 2010 (Final data collection date for primary outcome measure)|
Premenopausal Women who are not taking hormones or birth control. Ages 35-45 who have had a negative mammograph performed at the Mayo Clinic in Rochester within the last year.
Women Initiating Hormone Therapy and have had a negative mammogram preformed at the Mayo Clinic Rochester within the last year.
Women Initiating Tamoxifen who have had a negative mammogram preformed at the Mayo Clinic Rochester.
Contacts and Locations